um-uc-1 (CancerTools Org)
CancerTools Org is a verified supplier 
CancerTools Org manufactures this product 
99
Structured Review
CancerTools Org
um-uc-1
Um Uc 1, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/um-uc-1/UM-UC-1/custom%40160436%4041331244
Average 99 stars, based on 77 article reviews
Um Uc 1, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/um-uc-1/UM-UC-1/custom%40160436%4041331244
Average 99 stars, based on 77 article reviews
um-uc-1 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Transformation Assay:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Magnetic Resonance Imaging:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Imaging:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Glycoproteomics:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Derivative Assay:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Fluorescence:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Next-Generation Sequencing:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), Diagnostic Assay:Article Title: ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome Article Snippet: nostic biomarker but also suggest it may represent a promising therapeutic target for patients with advanced BLCA. Human bladder cancer cell lines 5637, RT112, HT1376, and T24 (Procell, Wuhan, China), |